Description
JARDY-MET 12.5/500MG: Achieve optimal blood sugar management for your Type 2 Diabetes with Jardy-Met 12.5/500mg. This powerful combination tablet contains Empagliflozin 12.5mg and Metformin Hydrochloride 500mg, providing a dual-action approach to controlling blood glucose levels. Empagliflozin works by helping your kidneys eliminate excess sugar from your body through urine, while Metformin reduces glucose production in the liver and enhances your body’s sensitivity to insulin. Jardy-Met 12.5/500mg is prescribed for adults with Type 2 Diabetes who need improved glycemic control, especially when Metformin alone or other antidiabetic agents are insufficient. In addition to its primary role in diabetes management, this combination offers the proven cardiovascular and renal protective benefits associated with empagliflozin, helping to reduce the risk of cardiovascular death, hospitalisation for heart failure, and progression of chronic kidney disease in suitable patients. Jardy-Met should be used alongside a healthy diet and regular exercise. As a Prescription-Only Medicine (P.O.M.), a valid prescription from a qualified healthcare professional is strictly required for purchase.
